About Decibel Therapeutics
Decibel Therapeutics is a company based in Cambridge (United States) founded in 2015 was acquired by Regeneron Pharmaceuticals in August 2023.. Decibel Therapeutics has raised $169.53 million across 4 funding rounds from investors including Regeneron Pharmaceuticals, Bessemer Venture Partners and BlackRock. The company has 62 employees as of March 31, 2022. Decibel Therapeutics operates in a competitive market with competitors including BeiGene, Serum Institute of India, BioNTech, Vir Biotechnology and Lyra Therapeutics, among others.
- Headquarter Cambridge, United States
- Employees 62 as on 31 Mar, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Decibel Therapeutics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$169.53 M (USD)
in 4 rounds
-
Latest Funding Round
$82.2 M (USD), Series D
Nov 09, 2020
-
Investors
Regeneron Pharmaceuticals
& 16 more
-
Employee Count
62
as on Mar 31, 2022
-
Acquired by
Regeneron Pharmaceuticals
(Aug 10, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Decibel Therapeutics
Decibel Therapeutics has successfully raised a total of $169.53M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $82.2 million completed in November 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series D — $82.2M
-
First Round
First Round
(13 Jan 2017)
- Investors Count 17
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2020 | Amount | Series D - Decibel Therapeutics | Valuation | Orbimed | |
| Jun, 2018 | Amount | Series C - Decibel Therapeutics | Valuation |
investors |
|
| Jul, 2017 | Amount | Series B - Decibel Therapeutics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Decibel Therapeutics
Decibel Therapeutics has secured backing from 17 investors, including venture fund and institutional investors. Prominent investors backing the company include Regeneron Pharmaceuticals, Bessemer Venture Partners and BlackRock. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
Investing in Life Sciences sectors like Healthcare and Biotechnology.
|
Founded Year | Domain | Location | |
|
Multiple sectors are targeted for venture capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Decibel Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Decibel Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Decibel Therapeutics Comparisons
Competitors of Decibel Therapeutics
Decibel Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BeiGene, Serum Institute of India, BioNTech, Vir Biotechnology and Lyra Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Vaccines and immuno-biological drugs for infectious diseases are manufactured.
|
|
| domain | founded_year | HQ Location |
Immunotherapeutics for cancer and other diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of infectious diseases
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for ENT diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Decibel Therapeutics
Frequently Asked Questions about Decibel Therapeutics
When was Decibel Therapeutics founded?
Decibel Therapeutics was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Where is Decibel Therapeutics located?
Decibel Therapeutics is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Decibel Therapeutics a funded company?
Decibel Therapeutics is a funded company, having raised a total of $169.53M across 4 funding rounds to date.
How many employees does Decibel Therapeutics have?
As of Mar 31, 2022, the latest employee count at Decibel Therapeutics is 62.
What does Decibel Therapeutics do?
Decibel Therapeutics was founded in 2015 as an early-stage biotechnology company located in Cambridge, United States. Focus is placed on developing injectable drugs for the inner ear across modalities such as antibodies, small molecules, and siRNAs. Operations target hearing disorders including ototoxicity from treatments, noise-induced hearing loss, and preservation of residual hearing with cochlear implants.
Who are the top competitors of Decibel Therapeutics?
Decibel Therapeutics's top competitors include BeiGene, BioNTech and Lyra Therapeutics.
Who are Decibel Therapeutics's investors?
Decibel Therapeutics has 17 investors. Key investors include Regeneron Pharmaceuticals, Bessemer Venture Partners, BlackRock, Orbimed, and Janus Henderson Investors.